文献速递骨软组织肉瘤与黑色素瘤支持与姑息治疗

COVID-19疫苗可模拟淋巴结转移:皮肤癌随访中的单中心研究

Coronavirus disease 2019 vaccine mimics lymph node metastases in patients undergoing skin cancer follow-up: A monocentre study.
PubMed 文献 · Eur J Cancer · 2021-06-26

该单中心研究纳入8例接受淋巴结切除且术前6周内接种COVID-19疫苗的黑色素瘤或Merkel细胞癌患者,发现3例(1例Merkel细胞癌、2例黑色素瘤)在肿瘤随访中被术前误诊为淋巴结转移,均位于疫苗接种同侧腋窝。作者强调疫苗相关淋巴结病在超声和FDG PET/CT上可类似转移,建议将疫苗尽可能接种于原发灶对侧。

要点

  • COVID-19疫苗相关淋巴结病可被超声和FDG PET/CT误判为淋巴结转移。
  • 肿瘤随访中需考虑接种史,避免不必要的淋巴结切除。
  • 建议疫苗尽量接种于原发灶对侧以降低误诊风险。

核心结论

  • COVID-19疫苗相关淋巴结病在肿瘤随访中可类似淋巴结转移,需警惕以避免误诊和不必要手术。

研究设计与样本

  • 单中心研究纳入8例接受淋巴结切除且术前6周内接种COVID-19疫苗的黑色素瘤或Merkel细胞癌患者。
  • 比较术前超声与组织病理结果的一致性。

主要发现

  • 8例中3例(1例Merkel细胞癌、2例黑色素瘤)在术前随访中被误诊为淋巴结转移。
  • 3例疑似转移均位于疫苗接种同侧(左上臂接种后左腋窝)。
  • 误诊导致2例选择性淋巴结切除、1例完整淋巴结清扫。

临床怎么用

  • 肿瘤随访评估淋巴结时需询问近期COVID-19疫苗接种史及接种部位。
  • 对疫苗接种同侧新发淋巴结肿大应谨慎解读影像,避免直接判定为转移。
  • 建议将COVID-19疫苗尽可能接种于原发灶对侧。

局限性

  • 单中心、样本量小(8例),结果需更大样本验证。
  • 仅纳入黑色素瘤和Merkel细胞癌患者,其他肿瘤类型需进一步研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: The coronavirus disease 2019 (COVID-19) pandemic has changed the lives of people around the world. Fortunately, sufficient vaccines are now available. Local reactions with ipsilateral lymphadenopathy are among the most common side effects. We investigated the impact of lymphadenopathy after COVID-19 vaccination on the value of ultrasound in tumour patients. PATIENTS AND METHODS: Patients with melanoma or Merkel cell carcinoma were included who underwent lymph node excision and received COVID-19 vaccination within 6 weeks before surgery. The consistency of the preoperative ultrasound findings with the histopathologic findings was investigated. RESULTS: Eight patients were included (two Merkel cell carcinoma and six melanoma patients) who underwent lymph node excision between 16th April 2021 and 19th May 2021 and had previously received COVID-19 vaccination. In three of the eight patients (one Merkel cell carcinoma and two melanoma patients), lymph node metastases were erroneously diagnosed preoperatively during tumour follow-up with physical examination, ultrasound, and or fluorodeoxyglucose (FDG)-positron emission tomography (PET)/computed tomography (CT). In these three patients, the suspected lymph node metastases were located in the left axilla after COVID-19 vaccination in the left upper arm, which resulted in selective lymph node removal in two patients and complete lymphadenectomy in one patient. CONCLUSION: COVID-19 vaccine-associated lymphadenopathy is expected to be observed much more frequently in the near future because of increasing vaccination rates. This cause of lymphadenopathy, which may in ultrasound as well as in FDG PET/CT resemble lymph node metastases, must be considered, especially in oncologic patients undergoing tumour follow-up. In addition, COVID-19 vaccination should be given as far away as possible from an underlying primary on the contralateral side to avoid oncologic misdiagnosis followed by malpractice.

来源:Eur J Cancer,查看原文。版权归原作者所有。

引用

  1. Placke JM, Reis H, Hadaschik E, et al. Coronavirus disease 2019 vaccine mimics lymph node metastases in patients undergoing skin cancer follow-up: A monocentre study. Eur J Cancer. 2021. PMID: 34280870. doi:10.1016/j.ejca.2021.06.023

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。